PYXIS ONCOLOGY INC (PYXS:NASDAQ)
$1.7 0 (0%)
Analysed PYXIS ONCOLOGY INC (PYXS:NASDAQ) News Sources
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
23-03-2026
yahoo.com
3 Penny Stocks With Market Caps Over $50M To Watch
06-02-2026
yahoo.com
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
03-02-2026
yahoo.com
3 Promising Penny Stocks With Market Caps Up To $300M
07-01-2026
yahoo.com
Wall Street Set to Open Higher Thursday as Inflation Rises Less Than Expected; Jobless Claims Decline
18-12-2025
yahoo.com
Investors Await Key Inflation, Employment Data as US Futures Rise Thursday Pre-Bell
18-12-2025
yahoo.com
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
18-12-2025
yahoo.com
3 Promising Penny Stocks With Over $90M Market Cap
09-12-2025
yahoo.com
Pyxis Oncology And 2 Other Promising Penny Stocks To Watch
04-11-2025
yahoo.com
Pyxis Oncology to Participate in Upcoming Investor Conferences
03-11-2025
yahoo.com
What is the current price of PYXIS ONCOLOGY INC (PYXS:NASDAQ)?
The current price of PYXIS ONCOLOGY INC (PYXS:NASDAQ) is $1.7.
PYXIS ONCOLOGY INC (PYXS:NASDAQ) absolute price change since previous trading day?
The absolute price change of PYXIS ONCOLOGY INC (PYXS:NASDAQ) since the previous trading day is $0.
PYXIS ONCOLOGY INC (PYXS:NASDAQ) percentage price change since previous trading day?
The percentage price change of PYXIS ONCOLOGY INC (PYXS:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for PYXIS ONCOLOGY INC (PYXS:NASDAQ)?
The most recent average sentiment score for PYXIS ONCOLOGY INC (PYXS:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for PYXIS ONCOLOGY INC (PYXS:NASDAQ)?
The most recent sentiment for PYXIS ONCOLOGY INC (PYXS:NASDAQ) is .
SEC-8K** Filing Available For PYXIS ONCOLOGY INC (PYXS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.